These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 808681)

  • 41. Comparison of three serological methods for the detection of hepatitis-associated antigen.
    White GB; Lasheen RM; Baillie MB; Turner GC
    J Clin Pathol; 1971 Feb; 24(1):8-12. PubMed ID: 4995479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter: Frequency of hepatitis-B antigen or antibody in household contacts of HBAg carriers.
    De la Concha EG; Masllorens FO; Hernandez-Guio C
    Lancet; 1974 Nov; 2(7891):1267-8. PubMed ID: 4139505
    [No Abstract]   [Full Text] [Related]  

  • 43. Au-SH antigen, hepatitis, and polyarteritis nodosa.
    Trépo C; Thivolet J; Prince AM
    Prog Immunobiol Stand; 1971; 5():99-103. PubMed ID: 4144999
    [No Abstract]   [Full Text] [Related]  

  • 44. Detection of serum hepatitis virus carriers by testing for the SH (Australia) antigen. A review of current methodology.
    Prince AM
    Vox Sang; 1970; 19(5):417-24. PubMed ID: 4993880
    [No Abstract]   [Full Text] [Related]  

  • 45. [Epidemiological and clinical significance of long-term carrier state of the Australia antigen (HB-Ag)].
    Chimbru VI; Kantorovich RA; Semendiaeva ME; Blinkov IL; Lorie NIu
    Sov Med; 1978 May; (5):35-9. PubMed ID: 675320
    [No Abstract]   [Full Text] [Related]  

  • 46. A new antigen-antibody system. Clinical significance in long-term carriers of hepatitis B surface antigen.
    Magnius LO; Lindholm A; Lundin P; Iwarson S
    JAMA; 1975 Jan; 231(4):356-9. PubMed ID: 45864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serological hepatitis B characteristics in clinical laboratory control sera].
    Lehmann H; Bruhn HD; Schlaak M
    Dtsch Med Wochenschr; 1976 Apr; 101(18):688-9. PubMed ID: 1261398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection in serum hepatitis of the Au-anti-Au immune complex and of the antigen and antibody by means of the modified electrosyneresis technique.
    Bedarida G; Zacchi T; Tassi GC
    Prog Immunobiol Stand; 1971; 5():75-80. PubMed ID: 4573948
    [No Abstract]   [Full Text] [Related]  

  • 49. Australia antigen in hemodialysis and renal transplantation units.
    Leski M; Grivaux C; Courouce-Pauty AM
    Vox Sang; 1970; 19(3):359-68. PubMed ID: 4993789
    [No Abstract]   [Full Text] [Related]  

  • 50. [Subtypes of serum hepatitis B antigen].
    Maksimović B
    Bilt Hematol Transfuz; 1975; 3(1-2):153-7. PubMed ID: 57774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody.
    Schmidt NJ; Gee PS; Lennette EH
    Appl Microbiol; 1971 Aug; 22(2):165-70. PubMed ID: 4255416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversed haemagglutination tests for the detection of hepatitis B antigen.
    Schuurs AH; Kacaki J
    Vox Sang; 1974; 27(2):97-114. PubMed ID: 4212322
    [No Abstract]   [Full Text] [Related]  

  • 53. Titres of Australia (hepatitis-associated) antigen in healthy carriers, leprosy, cirrhosis of the liver and acute hepatitis.
    Kelkar SS; Niphadkar KB; Khare PM
    Indian J Med Res; 1973 May; 61(5):684-8. PubMed ID: 4202881
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of complement--fixation and immunodiffusion tests for the detection of hepatitis-associated antigen.
    Papaevangelou GJ; Tsoukas S
    Pathol Microbiol (Basel); 1972; 38(5):346-53. PubMed ID: 4630759
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatitis B antigen in a leprosy hospital.
    Kelkar SS; Niphadkar KB; Khare PM; Junnarkar RV
    Bull World Health Organ; 1973 May; 48(5):555-8. PubMed ID: 4204489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Demonstration of hepatitis B (surface) antigen. A comparison of different serological methods (author's transl)].
    Lange W; Köhler H; Apodaca J
    Dtsch Med Wochenschr; 1975 Mar; 100(11):508-12. PubMed ID: 803894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic subtypes of hepatitis B antigen in Panama.
    Peters CJ; Reeves WC; Holland PV; Aster HJ
    Am J Epidemiol; 1974 May; 99(5):375-80. PubMed ID: 4133055
    [No Abstract]   [Full Text] [Related]  

  • 58. [In vitro stimulation of lymphocytes of HB antibody carriers by HB antigen (Australia antigen)].
    Koszinowski U; Thomssen R; Schober A
    Dtsch Med Wochenschr; 1973 Feb; 98(6):262-7. PubMed ID: 4684649
    [No Abstract]   [Full Text] [Related]  

  • 59. Optimising reagents for AU-SH-HA antigen screening.
    Molinari E; Eder G
    Prog Immunobiol Stand; 1971; 5():33-7. PubMed ID: 4633962
    [No Abstract]   [Full Text] [Related]  

  • 60. Australia antigen and hepatitis,
    Cossart YE
    Public Health; 1972 Nov-1973 Jan; 87(1):33-8. PubMed ID: 4211821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.